Stay updated on Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has updated its date references, adding new dates in August 2025 while removing older dates from July 2025.
    Difference
    0.5%
    Check dated 2025-08-24T09:38:33.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T05:26:54.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T01:10:20.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    1%
    Check dated 2025-08-02T20:05:38.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.
    Difference
    0.2%
    Check dated 2025-07-26T16:23:20.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.1%
    Check dated 2025-07-19T12:28:01.000Z thumbnail image

Stay in the know with updates to Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page.